Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses

The Lancet Infectious Diseases

Volumn 16, Issue 12, 2016, Pages 1409-1422

  Zhou, Kali ^a   Fitzpatrick, Thomas ^b   Walsh, Nick ^c   Kim, Ji Young ^c   Chou, Roger ^d   Lackey, Mellanye ^e   Scott, Julia ^c   Lo, Ying Ru ^c   Tucker, Joseph D ^f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INFECTION RATE; MENTAL HEALTH; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBSTANCE ABUSE; SYSTEMATIC REVIEW; HEALTH PROMOTION; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; MEDICATION COMPLIANCE; STANDARDS;

CONTINUITY OF PATIENT CARE; HEALTH PROMOTION; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MEDICATION ADHERENCE;

EID: 84995530829     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30208-0     Document Type: Article

References (99)

1. 1 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
2. 2 Chang, TT, Liaw, YF, Wu, SS, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52 (2010), 886–893.
3. 3 Poynard, T, McHutchison, J, Manns, M, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122 (2002), 1303–1313.
4. 4 van der Meer, AJ, Veldt, BJ, Feld, JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 308 (2012), 2584–2593.
5. 5 Bhattacharya, D, Thio, CL, Review of hepatitis B therapeutics. Clin Infect Dis 51 (2010), 1201–1208.
6. 6 Gutierrez, JA, Lawitz, EJ, Poordad, F, Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. J Viral Hepat 22 (2015), 861–870.
7. 7 van der Veen, YJ, Voeten, HA, de Zwart, O, Richardus, JH, Awareness, knowledge and self-reported test rates regarding hepatitis B in Turkish-Dutch: a survey. BMC Public Health, 10, 2010, 512.
8. 8 Chung, PW, Suen, SH, Chan, OK, Lao, TH, Leung, TY, Awareness and knowledge of hepatitis B infection and prevention and the use of hepatitis B vaccination in the Hong Kong adult Chinese population. Chin Med J (Engl) 125 (2012), 422–427.
9. 9 Guidelines for the screening, care and treatment of persons with hepatitis C infection, 2014, World Health Organization, Geneva http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/ (accessed Dec 26, 2015).
10. 10 Denniston, MM, Klevens, RM, McQuillan, GM, Jiles, RB, Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008. Hepatology 55 (2012), 1652–1661.
11. 11 Ng, MH, Chou, JY, Chang, TJ, et al. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addict Behav 38 (2013), 2089–2093.
12. 12 Allard, NL, MacLachlan, JH, Cowie, BC, The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment. Aust N Z J Public Health 39 (2015), 255–259.
13. 13 Yehia, BR, Schranz, AJ, Umscheid, CA, Lo Re, V 3rd, The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One, 9, 2014, e101554.
14. 14 Gower, E, Estes, C, Blach, S, Razavi-Shearer, K, Razavi, H, Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:suppl (2014), S45–S57.
15. 15 Ott, JJ, Stevens, GA, Groeger, J, Wiersma, ST, Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30 (2012), 2212–2219.
16. 16 Mandeville, KL, Krabshuis, J, Ladep, NG, Mulder, CJ, Quigley, EM, Khan, SA, Gastroenterology in developing countries: issues and advances. World J Gastroenterol 15 (2009), 2839–2854.
17. 17 Gardner, EM, McLees, MP, Steiner, JF, Del Rio, C, Burman, WJ, The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52 (2011), 793–800.
18. 18 World Health Organization. Draft global health sector strategies Viral hepatitis, 2016–2021. EB 138/30 Provisional agenda item 9.2, 2015, WHO, Geneva.
19. 19 Higgins, JP, Altman, DG, Sterne, JAC, Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions, 2011, John Wiley & Sons, London, England.
20. 20 Guyatt, GH, Oxman, AD, Vist, GE, et al., the GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
21. 21 Bastani, R, Glenn, BA, Herrmann, AK, et al. Community-based intervention to reduce liver cancer disparities in Asian Americans: a cluster randomized trial. Cancer Prev Res, 3, 2010 CN0-02 (abstr).
22. 22 Chen, MS Jr, Fang, DM, Stewart, SL, et al. Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study. Cancer Epidemiol Biomarkers Prev 22 (2013), 782–791.
23. 23 Juon, HS, Lee, S, Strong, C, Rimal, R, Kirk, GD, Bowie, J, Effect of a liver cancer education program on hepatitis B screening among Asian Americans in the Baltimore-Washington metropolitan area, 2009–2010. Prev Chronic Dis, 11, 2014, 130258.
24. 24 Taylor, VM, Hislop, TG, Tu, SP, et al. Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians. J Community Health 34 (2009), 165–172.
25. 25 Taylor, VM, Gregory Hislop, T, Bajdik, C, et al. Hepatitis B ESL education for Asian immigrants. J Community Health 36 (2011), 35–41.
26. 26 Taylor, VM, Bastani, R, Burke, N, et al. Evaluation of a hepatitis B lay health worker intervention for Cambodian Americans. J Community Health 38 (2013), 546–553.
27. 27 Drainoni, ML, Litwin, AH, Smith, BD, et al. Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting. Am J Public Health 102 (2012), e115–e121.
28. 28 Krauskopf, K, Kil, N, Sofianou, A, et al. Evaluation of an electronic health record prompt for hepatitis C antibody screening of baby boomers in primary care–a cluster randomized control trial. J Gen Intern Med 29 (2014), S88–S89.
29. 29 Litwin, AH, Smith, BD, Drainoni, ML, et al. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. Dig Liver Dis 44 (2012), 497–503.
30. 30 Carrión, JA, Gonzalez-Colominas, E, García-Retortillo, M, et al. A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C. J Hepatol 59 (2013), 926–933.
31. 31 Knott, A, Dieperink, E, Willenbring, ML, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 101 (2006), 2254–2262.
32. 32 Ho, SB, Brau, N, Cheung, R, et al. Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse. Clin Gastroenterol Hepatol 13 (2015), 2005–2014 e1–e3.
33. 33 Curcio, F, Di Martino, F, Capraro, C, et al. Together…to take care: multidisciplinary management of hepatitis C virus treatment in randomly selected drug users with chronic hepatitis. J Addict Med 4 (2010), 223–232.
34. 34 Neri, S, Bertino, G, Petralia, A, et al. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. J Clin Gastroenterol 44 (2010), e210–e217.
35. 35 Asthana, AK, Choong, J, Lubel, JS, Education does not improve hepatitis B screening uptake in those receiving cytotoxic chemotherapy-time for alternative strategies. J Gastroenterol Hepatol, 27, 2012, 162.
36. 36 Chakrabarty, G, Rice, P, Forton, DM, Randomized controlled trial of home-based self-administered dried blood spot testing versus written advice for community screening of hepatitis B contacts. Hepatology, 58, 2013, 616A.
37. 37 Hagedorn, H, Dieperink, E, Dingmann, D, et al. Integrating hepatitis prevention services into a substance use disorder clinic. J Subst Abuse Treat 32 (2007), 391–398.
38. 38 Hsu, L, Bowlus, CL, Stewart, SL, et al. Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci 58 (2013), 807–814.
39. 39 Koruk, I, Koruk, ST, Copur, AC, Simsek, Z, A intervention study to improve HBsAg testing and preventive practices for hepatitis B in an obstetrics hospital. Turk Silahli Kuvvetleri Koruyucu Hekim Bul 10 (2011), 287–292.
40. 40 Lee, R, Vu, K, Bell, CM, Hicks, LK, Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement. Curr Oncol 17 (2010), 32–38.
41. 41 Ma, GX, Gao, W, Tan, Y, Chae, WG, Rhee, J, A community-based participatory approach to a hepatitis B intervention for Korean Americans. Prog Community Health Partnersh 6 (2012), 7–16.
42. 42 Rosenberg, SD, Goldberg, RW, Dixon, LB, et al. Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness. Psychiatr Serv 61 (2010), 885–891.
43. 43 Sahajian, F, Bailly, F, Vanhems, P, et al., the Members of ADHEC. A randomized trial of viral hepatitis prevention among underprivileged people in the Lyon area of France. J Public Health (Oxf) 33 (2011), 182–192.
44. 44 van der Veen, YJ, van Empelen, P, de Zwart, O, Visser, H, Mackenbach, JP, Richardus, JH, Cultural tailoring to promote hepatitis B screening in Turkish Dutch: a randomized control study. Health Promot Int 29 (2014), 692–704.
45. 45 Craine, N, Whitaker, R, Perrett, S, Zou, L, Hickman, M, Lyons, M, A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons. Eur J Public Health 25 (2015), 351–357.
46. 46 Cullen, W, Stanley, J, Langton, D, Kelly, Y, Staines, A, Bury, G, Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation. Br J Gen Pract 56 (2006), 848–856.
47. 47 Helsper, CW, van Essen, GA, Bonten, MJ, de Wit, NJ, A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign. Fam Pract 27 (2010), 328–332.
48. 48 Hickman, M, McDonald, T, Judd, A, et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat 15 (2008), 250–254.
49. 49 Lacey, C, Ellen, S, Devlin, H, Wright, E, Mijch, A, Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Australas Psychiatry 15 (2007), 315–319.
50. 50 Merchant, RC, Baird, JR, Liu, T, Taylor, LE, Montague, BT, Nirenberg, TD, Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med 21 (2014), 752–767.
51. 51 Sahajian, F, Excler, G, Bailly, F, et al. Hepatitis C screening practices among private practitioners: impact of an information campaign. Gastroenterol Clin Biol 28 (2004), 714–719.
52. 52 Ahmed, I, Habibi, AN, Iqbal, J, Niaz, Z, Naqvi, AA, Improving outcome in hepatitis C management: a need for dedicated multi-disciplinary service to improve compliance with treatment. J Gastroenterol Hepatol Res 2 (2013), 737–739.
53. 53 Arora, S, Thornton, K, Murata, G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 364 (2011), 2199–2207.
54. 54 Bonkovsky, HL, Tice, AD, Yapp, RG, et al. Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. Am J Gastroenterol 103 (2008), 2757–2765.
55. 55 Bruce, RD, Eiserman, J, Acosta, A, Gote, C, Lim, JK, Altice, FL, Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. Am J Drug Alcohol Abuse 38 (2012), 206–212.
56. 56 Cacoub, P, Ouzan, D, Melin, P, et al. Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational study. World J Gastroenterol 14 (2008), 6195–6203.
57. 57 Cioe, PA, Stein, MD, Promrat, K, Friedmann, PD, A comparison of modified directly observed therapy to standard care for chronic hepatitis C. J Community Health 38 (2013), 679–684.
58. 58 Ho, SB, Brau, N, Cheung, R, et al. Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse. Clin Gastroenterol Hepatol 13 (2015), 2005–2014.
59. 59 Le Lan, C, Guillygomarc'h, A, Danielou, H, et al. A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. J Hepatol 56 (2012), 334–340.
60. 60 Larrey, D, Salse, A, Ribard, D, et al. Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirin. Clin Gastroenterol Hepatol 9 (2011), 781–785.
61. 61 Lubega, S, Agbim, U, Surjadi, M, Mahoney, M, Khalili, M, Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver Int 33 (2013), 999–1007.
62. 62 Merck Sharp & Dohme. Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671). 2007.
63. 63 Reimer, J, Schmidt, CS, Schulte, B, et al. Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial. Clin Infect Dis 57:suppl 2 (2013), S97–104.
64. 64 Renou, C, Lahmek, P, Pariente, A, et al. Impact of therapeutic education on the outcome of chronic hepatitis C treatment. Hepatology, 50, 2009, 729A.
65. 65 Rifai, MA, Moles, JK, Lehman, LP, Van der Linden, BJ, Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Psychosomatics 47 (2006), 112–121.
66. 66 Tait, JM, McIntyre, PG, McLeod, S, Nathwani, D, Dillon, JF, The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J Viral Hepat 17 (2010), 698–704.
67. 67 Poordad, F, Rustgi, V, Brown, RS, et al. The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial). Therap Adv Gastroenterol 8 (2015), 263–269.
68. 68 Matthews, HC, McLeod, MA, Oakes, K, et al. Perinatal hepatitis B in a high prevalence inner city population: direct electronic referral improves care. Gut 61 (2012), A79–A80.
69. 69 Mostert, MC, Richardus, JH, de Man, RA, Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work. J Hepatol 41 (2004), 1026–1030.
70. 70 Evon, DM, Simpson, K, Kixmiller, S, et al. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. Am J Gastroenterol 106 (2011), 1777–1786.
71. 71 Hirsch, AA, Lawrence, RH, Kern, E, Falck-Ytter, Y, Shumaker, DT, Watts, B, Implementation and evaluation of a multicomponent quality improvement intervention to improve efficiency of hepatitis C screening and diagnosis. Jt Comm J Qual Patient Saf 40 (2014), 351–357.
72. 72 Masson, CL, Delucchi, KL, McKnight, C, et al. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health 103 (2013), e81–e88.
73. 73 Chen, WL, Chiu, WT, Wu, MS, Hsu, MH, Tsai, SH, Translational research of telecare for the treatment of hepatitis C. Biomed Res Int, 2014, 2014, 195097.
74. 74 Hussein, M, Benner, JS, Lee, D, Sesti, AM, Battleman, DS, Brock-Wood, C, Propensity score matching in the evaluation of drug therapy management programs: an illustrative analysis of a program for patients with hepatitis C virus. Qual Manag Health Care 19 (2010), 25–33.
75. 75 Merck Sharp & Dohme. Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED). 2009.
76. 76 Merck Sharp & Dohme. Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252). 2009.
77. 77 Ramsey, SE, Engler, PA, Stein, MD, et al. Effect of CBT on Depressive Symptoms in Methadone Maintenance Patients Undergoing Treatment for Hepatitis C. J Addict Res Ther 2 (2011), 2–10.
78. 78 Aspinall, EJ, Doyle, JS, Corson, S, et al. Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis. Eur J Epidemiol 30 (2015), 115–129.
79. 79 Meyer, JP, Moghimi, Y, Marcus, R, Lim, JK, Litwin, AH, Altice, FL, Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic hepatitis C care continuum. Int J Drug Policy 26 (2015), 922–935.
80. 80 Sun, X, Patnode, CD, Williams, C, Senger, CA, Kapka, TJ, Whitlock, EP, Interventions to improve patient adherence to hepatitis C treatment: comparative effectiveness, 2012, Agency for Healthcare Research and Quality, Rockville, MD.
81. 81 Jones, LB G, McCoy, E, Beynon, C, McVeigh, J, Bellis, M, A systematic review of the effectiveness and cost-effectiveness of interventions aimed at raising awareness and engaging with groups who are at an increased risk of hepatitis B and C infection, 2012, Centre for Public Health, Liverpool John Moores University, Liverpool.
82. 82 Shah, HA, Abu-Amara, M, Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review. Clin Gastroenterol Hepatol 11 (2013), 922–933.
83. 83 Norton, BL, Voils, CI, Timberlake, SH, et al. Community-based HCV screening: knowledge and attitudes in a high risk urban population. BMC Infect Dis, 14, 2014, 74.
84. 84 Glenton, C, Colvin, CJ, Carlsen, B, et al. Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: qualitative evidence synthesis. Cochrane Database Syst Rev, 10, 2013 CD010414.
85. 85 Mwai, GW, Mburu, G, Torpey, K, Frost, P, Ford, N, Seeley, J, Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc, 16, 2013, 18586.
86. 86 Kredo, T, Adeniyi, FB, Bateganya, M, Pienaar, ED, Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. Cochrane Database Syst Rev, 7, 2014 CD007331.
87. 87 Joshi, R, Alim, M, Kengne, AP, et al. Task shifting for non-communicable disease management in low and middle income countries–a systematic review. PLoS One, 9, 2014, e103754.
88. 88 Bassett, IV, Walensky, RP, Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis 50:suppl 3 (2010), S77–S84.
89. 89 Johnson, JK, Miller, SH, Horowitz, SD, Systems based practice: improving the safety and quality of patient care by recognizing and improving the systems in which we work. Henriksen, K, Battles, JB, Keyes, MA, Grady, ML, (eds.) Advances in patient safety: new directions and alternative approaches (vol 2: culture and redesign), 2008, Agency for Healthcare Research and Quality, Rockville, MD.
90. 90 Were, MC, Shen, C, Tierney, WM, et al. Evaluation of computer-generated reminders to improve CD4 laboratory monitoring in sub-Saharan Africa: a prospective comparative study. J Am Med Inform Assoc 18 (2011), 150–155.
91. 91 Nelson, PK, Mathers, BM, Cowie, B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378 (2011), 571–583.
92. 92 Willenbring, ML, Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 19:suppl 3 (2005), S227–S237.
93. 93 Hoang, T, Goetz, MB, Yano, EM, et al. The impact of integrated HIV care on patient health outcomes. Med Care 47 (2009), 560–567.
94. 94 Sylla, L, Bruce, RD, Kamarulzaman, A, Altice, FL, Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy 18 (2007), 306–312.
95. 95 Grebely, J, Oser, M, Taylor, LE, Dore, GJ, Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels. J Infect Dis 207:suppl 1 (2013), S19–S25.
96. 96 Morrill, JA, Shrestha, M, Grant, RW, Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 20 (2005), 754–758.
97. 97 Hosaka, T, Suzuki, F, Kobayashi, M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 58 (2013), 98–107.
98. 98 Petersen, T, Townsend, K, Gordon, LA, et al. High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study. Hepatol Int 10 (2016), 310–319.
99. 99 Peters, DH, Tran, NT, Adam, T, Implementation research in health: a practical guide. http://who.int/alliance-hpsr/alliancehpsr_irpguide.pdf, 2013 (accessed April 16, 2016).